Latest & greatest articles for beclomethasone

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on beclomethasone or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on beclomethasone and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for beclomethasone

1. Beclomethasone

Beclomethasone Top results for beclomethasone - Trip Database or use your Google+ account Find evidence fast My query is: English Français Deutsch Čeština Español Magyar Svenska ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing (...) the search button. An example search might look like (#1 or #2) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for beclomethasone The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines

Trip Latest and Greatest2018

2. Inhaled beclomethasone/formoterol in idiopathic pulmonary fibrosis: a randomised controlled exploratory study

Inhaled beclomethasone/formoterol in idiopathic pulmonary fibrosis: a randomised controlled exploratory study Inhaled beclomethasone/formoterol in idiopathic pulmonary fibrosis: a randomised controlled exploratory study To the Editor: We hypothesise that inflammation plays a role in idiopathic pulmonary fibrosis (IPF) and that the harm associated with corticosteroid-containing regimens in IPF may relate to local beneficial effects being counterbalanced by deleterious systemic effects [1, 2 (...) consequence of platelet activation is thrombosis, and the association between IPF and thrombotic vascular diseases is well documented [8]. We propose that markers of platelet activation reflect a pathological process in IPF and may have utility as a biomarker. We report the findings of an exploratory, double-blind, placebo-controlled, randomised, crossover trial of “ultrafine” inhaled beclomethasone/formoterol in IPF. Patients attending a single tertiary centre were randomised to receive either 4weeks

ERJ open research2017 Full Text: Link to full Text with Trip Pro

3. Intranasal triamcinolone versus intranasal beclomethasone for acute and chronic sinus inflammation: a review of comparative clinical effectiveness and safety

Intranasal triamcinolone versus intranasal beclomethasone for acute and chronic sinus inflammation: a review of comparative clinical effectiveness and safety Intranasal triamcinolone versus intranasal beclomethasone for acute and chronic sinus inflammation: a review of comparative clinical effectiveness and safety Intranasal triamcinolone versus intranasal beclomethasone for acute and chronic sinus inflammation: a review of comparative clinical effectiveness and safety CADTH Record Status (...) This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Intranasal triamcinolone versus intranasal beclomethasone for acute and chronic sinus inflammation: a review of comparative clinical effectiveness and safety. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response - Summary with Critical Appraisal. 2013 Authors' conclusions Findings from

Health Technology Assessment (HTA) Database.2014

5. Cost-effectiveness and cost-utility of beclomethasone/formoterol versus fluticasone propionate/salmeterol in patients with moderate to severe asthma

Cost-effectiveness and cost-utility of beclomethasone/formoterol versus fluticasone propionate/salmeterol in patients with moderate to severe asthma Cost-effectiveness and cost-utility of beclomethasone/formoterol versus fluticasone propionate/salmeterol in patients with moderate to severe asthma Cost-effectiveness and cost-utility of beclomethasone/formoterol versus fluticasone propionate/salmeterol in patients with moderate to severe asthma Gerzeli S, Rognoni C, Quaglini S, Cavallo MC (...) , Cremonesi G, Papi A Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The objective was to assess the cost-effectiveness of beclomethasone with formoterol versus fluticasone propionate with salmeterol, for patients with moderate-to-severe

NHS Economic Evaluation Database.2013

6. Qnasl (beclomethasone dipropionate) Nasal Aerosol

Qnasl (beclomethasone dipropionate) Nasal Aerosol Drug Approval Package: Qnasl (beclomethasone dipropionate) NDA #202813 Drug Approval Package U.S. Food & Drug Administration Enter Search terms Drug Approval Package - Qnasl (beclomethasone dipropionate) Nasal Aerosol 80 mcg Company: Teva Branded Pharmaceutical Products R&D, Inc. Application No.: 202813 Approval Date: 03/23/2012 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. (PDF

FDA - Drug Approval Package2012

7. Randomised controlled trial: In children and adolescents with mild persistent asthma, daily beclomethasone reduces treatment failure compared with rescue beclomethasone plus albuterol

Randomised controlled trial: In children and adolescents with mild persistent asthma, daily beclomethasone reduces treatment failure compared with rescue beclomethasone plus albuterol In children and adolescents with mild persistent asthma, daily beclomethasone reduces treatment failure compared with rescue beclomethasone plus albuterol | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here In children and adolescents with mild persistent asthma, daily beclomethasone reduces treatment failure compared with rescue beclomethasone plus albuterol Article Text

Evidence-Based Medicine (Requires free registration)2011

8. Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial.

Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial. 21324520 2011 02 21 2011 03 29 2017 02 20 1474-547X 377 9766 2011 Feb 19 Lancet (London, England) Lancet Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial. 650-7 10.1016/S0140-6736(10)62145-9 Daily inhaled corticosteroids are an (...) effective treatment for mild persistent asthma, but some children have exacerbations even with good day-to-day control, and many discontinue treatment after becoming asymptomatic. We assessed the effectiveness of an inhaled corticosteroid (beclomethasone dipropionate) used as rescue treatment. In this 44-week, randomised, double-blind, placebo-controlled trial we enrolled children and adolescents with mild persistent asthma aged 5-18 years from five clinical centres in the USA. A computer-generated

Lancet2011

9. Comparison of the anti-inflammatory effects of extra-fine hydrofluoroalkane-beclomethasone vs fluticasone dry powder inhaler on exhaled inflammatory markers in childhood asthma

Comparison of the anti-inflammatory effects of extra-fine hydrofluoroalkane-beclomethasone vs fluticasone dry powder inhaler on exhaled inflammatory markers in childhood asthma 18592826 2008 07 02 2008 08 18 2016 11 24 1081-1206 100 6 2008 Jun Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology Ann. Allergy Asthma Immunol. Comparison of the anti-inflammatory effects of extra-fine hydrofluoroalkane-beclomethasone vs fluticasone (...) dry powder inhaler on exhaled inflammatory markers in childhood asthma. 601-7 10.1016/S1081-1206(10)60052-X Extra-fine hydrofluoroalkane-beclomethasone differs from other inhaled corticosteroids by its fine aerosol characteristics. Therefore, extra-fine hydrofluoroalkane-beclomethasone may be particularly useful for treating peripheral airway inflammation in asthma. To analyze the anti-inflammatory effects of extra-fine hydrofluoroalkane-beclomethasone vs fluticasone dry powder inhaler (DPI

EvidenceUpdates2008

10. Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children.

Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children. BACKGROUND: Beclomethasone dipropionate (BDP) and budesonide (BUD) are commonly prescribed inhaled corticosteroids for the treatment of asthma. Fluticasone propionate (FP) is newer agent with greater potency in in-vitro assays. OBJECTIVES: To compare the efficacy and safety of Fluticasone to Beclomethasone or Budesonide in the treatment of chronic asthma. SEARCH STRATEGY: We searched the Cochrane Airways (...) Group trial register (January 2007) and reference lists of articles. We contacted trialists and pharmaceutical companies for additional studies and searched abstracts of major respiratory society meetings (1997 to 2006). SELECTION CRITERIA: Randomised trials in children and adults comparing Fluticasone to either Beclomethasone or Budesonide in the treatment of chronic asthma. DATA COLLECTION AND ANALYSIS: Two reviewers independently assessed articles for inclusion and methodological quality. One

Cochrane2007

11. Meta-analysis: the efficacy of rectal beclomethasone dipropionate vs. 5-aminosalicylic acid in mild to moderate distal ulcerative colitis

Meta-analysis: the efficacy of rectal beclomethasone dipropionate vs. 5-aminosalicylic acid in mild to moderate distal ulcerative colitis Meta-analysis: the efficacy of rectal beclomethasone dipropionate vs. 5-aminosalicylic acid in mild to moderate distal ulcerative colitis Meta-analysis: the efficacy of rectal beclomethasone dipropionate vs. 5-aminosalicylic acid in mild to moderate distal ulcerative colitis Manguso F, Balzano A CRD summary The authors concluded that treatment with rectal (...) beclomethasone dipropionate is as effective as 5-aminosalicylic acid in symptom improvement for active left-sided UC, proctosigmoiditis and proctitis. Despite potential methodological limitations amongst the included studies, the authors' conclusions are likely to be reliable. Authors' objectives To compare the efficacy of rectal beclomethasone dipropionate (BDP) with 5-aminosalicylic acid (5-ASA) in treating mild to moderate distal ulcerative colitis (UC). Searching MEDLINE (1966 to March 2007), EMBASE

DARE.2007

12. Symptomatic use of beclomethasone-albuterol and regular use of beclomethasone did not differ for control of mild asthma

Symptomatic use of beclomethasone-albuterol and regular use of beclomethasone did not differ for control of mild asthma Symptomatic use of beclomethasone-albuterol and regular use of beclomethasone did not differ for control of mild asthma | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name (...) or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Symptomatic use of beclomethasone-albuterol and regular use of beclomethasone did not differ for control of mild asthma Article Text Therapeutics Symptomatic use of beclomethasone-albuterol and regular use of beclomethasone did not differ for control of mild asthma Statistics

Evidence-Based Medicine (Requires free registration)2007

13. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma.

Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. 17507703 2007 05 17 2007 05 29 2016 08 03 1533-4406 356 20 2007 May 17 The New England journal of medicine N. Engl. J. Med. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. 2040-52 Treatment guidelines recommend the regular use of inhaled corticosteroids for patients with mild persistent asthma. We investigated whether the symptom-driven use of a combination of beclomethasone (...) dipropionate and albuterol (also known as salbutamol) in a single inhaler would be as effective as the regular use of inhaled beclomethasone and superior to the as-needed use of inhaled albuterol. We conducted a 6-month, double-blind, double-dummy, randomized, parallel-group trial. After a 4-week run-in, patients with mild asthma were randomly assigned to receive one of four inhaled treatments: placebo twice daily plus 250 microg of beclomethasone and 100 microg of albuterol in a single inhaler as needed

NEJM2007

14. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review

Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review Dyer M J, Halpin D M, Stein K CRD summary This review evaluated (...) . Studies published as abstracts were only included if they reported sufficient information to permit a validity assessment. Study selection Study designs of evaluations included in the review RCTs and systematic reviews published in or after 2004 were eligible. None of the included studies was a parallel trial. Specific interventions included in the review Studies comparing the inhalation of ciclesonide with that of budesonide, beclomethasone or fluticasone were eligible for inclusion. Studies on oral

DARE.2006

15. Hydrofluoroalkane-134a beclomethasone as a dominant economic asthma therapy

Hydrofluoroalkane-134a beclomethasone as a dominant economic asthma therapy Hydrofluoroalkane-134a beclomethasone as a dominant economic asthma therapy Hydrofluoroalkane-134a beclomethasone as a dominant economic asthma therapy Malone D C, Luskin A T Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment (...) on the reliability of the study and the conclusions drawn. Health technology Two treatments for patients with persistent asthma were examined. The treatments were two widely used inhaled corticosteroids, hydrofluoroalkane beclomethasone (HDP-BDP) (QVAR) and chlorofluorocarbon beclomethasone (CFC-BDP) (Vanceril). Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population The study population comprised patients with persistent asthma. Setting The setting of the study

NHS Economic Evaluation Database.2003

16. The cost effectiveness of chlorofluorocarbon-free beclomethasone dipropionate in the treatment of chronic asthma: a cost model based on a 1-year pragmatic, randomised clinical study

The cost effectiveness of chlorofluorocarbon-free beclomethasone dipropionate in the treatment of chronic asthma: a cost model based on a 1-year pragmatic, randomised clinical study The cost effectiveness of chlorofluorocarbon-free beclomethasone dipropionate in the treatment of chronic asthma: a cost model based on a 1-year pragmatic, randomised clinical study The cost effectiveness of chlorofluorocarbon-free beclomethasone dipropionate in the treatment of chronic asthma: a cost model based (...) on a 1-year pragmatic, randomised clinical study Price D, Haughney J, Duerden M, Nicholls C, Moseley C Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of hydrofluoroalkane 134a-beclomethasone dipropionate (HFA-BDP

NHS Economic Evaluation Database.2002

17. Fluticasone versus beclomethasone or budesonide for chronic asthma.

Fluticasone versus beclomethasone or budesonide for chronic asthma. BACKGROUND: Beclomethasone dipropionate (BDP) and budesonide (BUD) are commonly prescribed inhaled corticosteroids for the treatment of asthma, Fluticasone propionate (FP) is newer agent with greater potency in in-vitro assays. OBJECTIVES: To compare the efficacy and safety of Fluticasone to Beclomethasone or Budesonide in the treatment of chronic asthma. SEARCH STRATEGY: We searched the Cochrane Airways Group Trial Register (...) (1999) and reference lists of articles. We contacted trialists and pharmaceutical companies for additional studies and searched abstracts of major respiratory society meetings (1997-1999). SELECTION CRITERIA: Randomised trials in children and adults comparing Fluticasone to either Beclomethasone or Budesonide in the treatment of chronic asthma. Two reviewers independently assessed articles for inclusion and methodological quality. DATA COLLECTION AND ANALYSIS: One reviewer extracted data

Cochrane2002

18. Inhaled beclomethasone versus budesonide for chronic asthma.

Inhaled beclomethasone versus budesonide for chronic asthma. BACKGROUND: Beclomethasone dipropionate (BDP) and budesonide (BUD) are used widely in the treatment of chronic asthma. The two drugs have different in vitro pharmacokinetic characteristics. It is unclear whether this translates into clinically significant differences in efficacy or safety when treating children and adults with chronic asthma. OBJECTIVES: To assess clinical outcomes in studies which have compared inhaled BDP and BUD

Cochrane2002

19. Beclomethasone at different doses for chronic asthma (review).

Beclomethasone at different doses for chronic asthma (review). BACKGROUND: Beclomethasone dipropionate (BDP) is available in a wide range of daily doses for the treatment of long-term asthma. OBJECTIVES: To assess the evidence for a dose response relationship for BDP in the treatment of long-term asthma. SEARCH STRATEGY: We searched the Cochrane Airways Group trial register, Cochrane Controlled Trials Register (The Cochrane Library issue 1 1999) and references lists of articles. Authors

Cochrane2001

20. Beclomethasone for asthma in children: effects on linear growth.

Beclomethasone for asthma in children: effects on linear growth. BACKGROUND: Inhaled steroids play a central role in the management of childhood asthma. There is concern about their side effects, especially on growth. However asthma may also cause growth retardation. Growth rates are not stable, so randomised controlled parallel group studies are needed to assess the impact of inhaled steroids on growth. This review is confine to one inhaled steroid, beclomethasone, that is known to have (...) significant levels of systemic absorption. OBJECTIVES: To determine whether inhaled beclomethasone cause significant delay in the linear growth of children with asthma. SEARCH STRATEGY: The Cochrane Airways Group asthma register was searched. Bibliographies from included studies, and known reviews were searched for additional citations. Personal contact with colleagues and researchers working in the field of asthma were made to identify potentially relevant trials. SELECTION CRITERIA: Randomized

Cochrane2000